The PharmaLedger project aims to bring value and trust to the healthcare ecosystem through blockchain technology. Together, we will create a Blockchain-based framework for the efficient digitisation of the healthcare industry. The goal of the project is to provide a widely trusted platform that will support the design and adoption of blockchain-enabled healthcare solutions while accelerating delivery of innovation that will benefit the entire ecosystem - from manufacturers to patients. Together, we are a Public/Private consortium comprised of 29 partners from 13 countries. This includes 12 large pharmaceutical companies; highly innovative technology SMEs specialising in blockchain development, security, privacy and business intelligence; universities and research institutes specialising in pharmacoeconomic analysis, research of patient requirements, big data analytics and electronic health records; leading clinical trials companies; supply chain partners; patient representatives; and leading healthcare service providers. The PharmaLedger project is funded through the Innovative Medicines Initiative (IMI) 2 Joint Undertaking and listed under grant agreement No.85399. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme, and the European Federation of Pharmaceutical Industries and Associations (EFPIA).